Home | News | Contact | Links | Web Map | Print
Friday, May 24, 2013   English   Español
EuroEspes
La EmpresaInternacionalRetosPublicaciones
Relaciones Institucionales

Personalization and Optimization of Treatment
ESTABLISHMENT OF THE BEST SUITED DRUG FOR EACH PERSON
ESTABLISHMENT OF THE CORRECT DOSE FOR EACH PERSON

Until now, drug management was carried out “en masse”, in such a way that the same drug and the same dose was prescribed to all patients.

This may entail:

  • Adverse reactions
  • An efficacy rate of 10-70%
  • Toxicity and even death

Optimization
On studying the genes which intervene in the metabolism of drugs, we find different profiles:

    Ultra-rapid Metabolizer (UM)
    When there is a duplication of an active gene. It is necessary to increase the dosage of the drug.

    Extensive Metabolizer (EM)
    Two active alleles. Standard dose.

    Intermediate Metabolizer (IM)
    Formed by one active and one inactive allele. Slightly lower drug dosage. Multi-drug treatments should be avoided.

    Poor Metabolizer (PM)
    Formed by two inactive alleles. Reduce the dosage of the drug; the risk of suffering side-effects increases.

* Any variation in dosage must ALWAYS be recommended and supervised by your doctor.

tarjeta farmacogenetica

What is Pharmacogenetics?

Pharmacogenetics is the study of the different response to drugs of different people. You will be able to find out which drugs are most appropriate for you, by undergoing a simple genetic analysis. With the results, you will be given a list of the drugs which are suited to you, and the appropriate dosage. We personalize your treatment.

 

 

 

 

YOU ONLY NEED A SINGLE ANALYSIS, AS YOUR GENETIC INFORMATION IS INVARIABLE OVER TIME

 


Audio file:

Hear Julia Otero interview Dr. Cacabelos (in Spanish) about Personalized Medicine on “Onda Cero” radio.


Related articles:

Solicite más información: info@euroespes.com


atras imprimir

News

Sabías Que?

Pharmacogenetics is the path towards a personalized medicine which will allow the optimization of treatment, a reduction in costs and in side-effects, and the profitability of the resources devoted to the health of the population.


Find out more »



Contact Us:
[P] +34 902 154 476
[M] +34 608 322 207
email: info@euroespes.com

© 2009 EuroEspes
Biomedical Research Center
Santa Marta de Babío s/n
15165 Bergondo, Coruña, Spain
JOIN US IN
RSS

Bureau veritas